Cargando…
Vaccine hesitancy against COVID-19 vaccine over time in Nigeria
INTRODUCTION: While COVID-19 pandemic is an ongoing threat for our lives, the rapid development of effective vaccines against COVID-19 provided us hopes for manageable disease control. However, vaccine hesitancy across the globe is a concern which could attenuate efforts of disease control. This stu...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028343/ https://www.ncbi.nlm.nih.gov/pubmed/36959055 http://dx.doi.org/10.1016/j.vaccine.2023.03.029 |
_version_ | 1784909930120085504 |
---|---|
author | Sato, Ryoko |
author_facet | Sato, Ryoko |
author_sort | Sato, Ryoko |
collection | PubMed |
description | INTRODUCTION: While COVID-19 pandemic is an ongoing threat for our lives, the rapid development of effective vaccines against COVID-19 provided us hopes for manageable disease control. However, vaccine hesitancy across the globe is a concern which could attenuate efforts of disease control. This study examined the extent and trend of vaccine hesitancy in Nigeria. METHODS: The COVID-19 National Longitudinal Phone Survey conducted between 2020 and 2021 was used for the analysis. The extent and trend of vaccine hesitancy across different zones within Nigeria, over time, as well as reasons of the hesitancy were evaluated. RESULTS: Vaccine hesitancy was more prevalent in southern zones, which on average have better socioeconomic status than northern zones. Overtime, vaccine hesitancy became more prevalent, and respondents became more resistant to the COVID-19 vaccine across the country. CONCLUSION: While the nature of interventions to improve the uptake of COVID-19 vaccine should differ by regions due to differential barriers to vaccination, it might be important to prebunk and debunk any misinformation related to COVID-19 vaccine to mitigate the vaccine hesitancy across the country. |
format | Online Article Text |
id | pubmed-10028343 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-100283432023-03-21 Vaccine hesitancy against COVID-19 vaccine over time in Nigeria Sato, Ryoko Vaccine Short Communication INTRODUCTION: While COVID-19 pandemic is an ongoing threat for our lives, the rapid development of effective vaccines against COVID-19 provided us hopes for manageable disease control. However, vaccine hesitancy across the globe is a concern which could attenuate efforts of disease control. This study examined the extent and trend of vaccine hesitancy in Nigeria. METHODS: The COVID-19 National Longitudinal Phone Survey conducted between 2020 and 2021 was used for the analysis. The extent and trend of vaccine hesitancy across different zones within Nigeria, over time, as well as reasons of the hesitancy were evaluated. RESULTS: Vaccine hesitancy was more prevalent in southern zones, which on average have better socioeconomic status than northern zones. Overtime, vaccine hesitancy became more prevalent, and respondents became more resistant to the COVID-19 vaccine across the country. CONCLUSION: While the nature of interventions to improve the uptake of COVID-19 vaccine should differ by regions due to differential barriers to vaccination, it might be important to prebunk and debunk any misinformation related to COVID-19 vaccine to mitigate the vaccine hesitancy across the country. Elsevier Ltd. 2023-04-24 2023-03-21 /pmc/articles/PMC10028343/ /pubmed/36959055 http://dx.doi.org/10.1016/j.vaccine.2023.03.029 Text en © 2023 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Short Communication Sato, Ryoko Vaccine hesitancy against COVID-19 vaccine over time in Nigeria |
title | Vaccine hesitancy against COVID-19 vaccine over time in Nigeria |
title_full | Vaccine hesitancy against COVID-19 vaccine over time in Nigeria |
title_fullStr | Vaccine hesitancy against COVID-19 vaccine over time in Nigeria |
title_full_unstemmed | Vaccine hesitancy against COVID-19 vaccine over time in Nigeria |
title_short | Vaccine hesitancy against COVID-19 vaccine over time in Nigeria |
title_sort | vaccine hesitancy against covid-19 vaccine over time in nigeria |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028343/ https://www.ncbi.nlm.nih.gov/pubmed/36959055 http://dx.doi.org/10.1016/j.vaccine.2023.03.029 |
work_keys_str_mv | AT satoryoko vaccinehesitancyagainstcovid19vaccineovertimeinnigeria |